Rejeunesse Deep Skin Filler
Cross-linked Hyaluronic Acid 25mg/ml
Rejeunesse Deep Skin Filler is a premium dermal filler containing 100% cross-linked hyaluronic acid with high-density integration. Utilizing UPHEC purification technology, it achieves 98.7% BDDE elimination and 99.2% endotoxin reduction. Clinical studies show 12-month duration in 89% of patients with 95% hydration retention capacity, meeting ISO 13485 standards for medical aesthetics.
- Structural Support: Provides 360° facial volume restoration with natural-looking results
- Longevity: Clinically proven 12-month duration in majority of patients
- Hydration: Maintains 95% water-binding capacity for optimal skin plumping
- Safety: Non-pyrogenic formula with ultra-low endotoxin levels
Cross-linked Hyaluronic Acid
UPHEC purification process
Pre-filled sterile syringe with needle
Refrigeration required
18 months unopened
Contraindications: Hypersensitivity to hyaluronic acid; Active skin infections; Autoimmune disorders
Adverse Effects: Temporary swelling (15%), redness (12%), bruising (8%) in clinical trials
Professional Note: Results vary based on injection technique and individual tissue response
• Rejeunesse Deep Skin Filler requires prescription and professional administration
• Must be administered by licensed aesthetic practitioners only
• Always follow aseptic techniques during administration
• Monitor for vascular compromise during injection
• Manufacturer not liable for improper storage or administration errors
We are an authorized wholesale distributor of medical aesthetic products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be prescribed and administered by qualified medical professionals in accordance with local regulations. For actual product specifications, please contact our sales representatives as packaging may vary. Product images and specifications shown are for reference only and may differ from actual products.
Reviews
There are no reviews yet.